from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1854c/ndh

LFCtreatmentdescriptionclass of inhibitor

-0.627

Amikacinug/mL Amikacintranslation

-0.539

Cap5-10ug/mL Capreomycintranslation

-0.832

Rox10-50 ug/mL Roxithromycintranslation

0.558

SM2-5 ug/mL Streptomycintranslation

-1.223

Tet5-10 ug/mL Tetracyclinetranslation

-0.631

Rif0.2-5ug/mL Rifampicintranscription

-0.793

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.168

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.574

CPZ10-50 ug/mL Chlorpromazinerespiration

0.187

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.327

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.569

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.261

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.001

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.088

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.331

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.304

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.687

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.495

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.778

KCN5-20 ug/mL Potassium cyaniderespiration

1.502

NaN30.2-2 mM Sodium aziderespiration

-0.648

Nigericin50 uM Nigericinrespiration

1.763

TRC10-150 ug/mL Triclosanrespiration

-0.227

TRZ10-25 ug/mL Thioridazinerespiration

-0.734

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.051

menadione6-10 ug/mL Menadionerespiration

0.731

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.674

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.038

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.806

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.121

NRP_1Non-replicating persistence stage 1dosRassociated

-0.069

Amp0.2mg/mL AmpicillincellWall

-0.641

Cephalexin20-100 ug/mL CephalexincellWall

0.386

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.897

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.310

EMB10-20 ug/mL EthambutolcellWall

0.734

Eta12-40 ug/mL EthionamidecellWall

0.639

INH0.2-0.4 ug/mL IsoniazidcellWall

0.011

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.202

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.421

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.127

BZA0.12 mg/mL BenzamidearomaticAmides

0.009

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.225

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.281

H2O24 mM hydrogen peroxideDNAdamaging

-0.053

Levo10 ug/mL LevofloxacinDNAdamaging

-0.166

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.179

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.286

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.246

UVUV-irradiationDNAdamaging

-0.398

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.461

Antimycin12.5-50 ug/mL Antimycin A?

-1.619

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.433

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.095

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.223

PA8240.2-2 ug/mL PA-824?

2.673

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.319

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-1.719

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.015

methoxatin10-20 ug/mL Methoxatin?